HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (4- nitrobenzylidene)- 2- naphthohydrazide

inhibits IkappaB kinase beta; structure in first source

Also Known As:

LASSBio 1524; LASSBio-1524

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrazines: 379
  - Hydrazones: 500
    - N-(4-nitrobenzylidene)-2-naphthohydrazide: 2

Experts

1.	Cordeiro, Natália: 1 article (01/2020)
2.	Fernandes, Patricia Dias: 1 article (01/2020)
3.	Fraga, Carlos Alberto Manssour: 1 article (01/2020)
4.	Freitas, Rosana Helena Coimbra Nogueira: 1 article (01/2020)
5.	Avila, Carolina M: 1 article (04/2011)
6.	Barreiro, Eliezer J: 1 article (04/2011)
7.	Fraga, Carlos A M: 1 article (04/2011)
8.	Gonçalves, Arlan S: 1 article (04/2011)
9.	Lopes, Alexandra B: 1 article (04/2011)
10.	Miranda, Ana Luisa P: 1 article (04/2011)

Related Diseases

1.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/01/2020 - "Our data may suggest LASSBio-1524 and its analogs (LASSBio-1760, LASSBio-1763, and LASSBio-1764) as promising candidates for new prototypes designed to treat inflammatory bowel diseases. "
2.	Edema (Dropsy) 04/01/2011 - "The NAH derivative LASSBio-1524 (3), was able to suppress arachidonic acid-induced edema formation in a dose-dependent manner, demonstrating an in vivo anti-inflammatory effect. "

Related Drugs and Biologics

1.	Arachidonic Acid (Vitamin F)